Kilitch Drugs(I) Ltd

NSE: KILITCH · BSE: 524500 · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹197.61
Market cap: ₹690.9 Cr
Revenue (annual): ₹235.5 Cr
Net profit (annual): ₹30.17 Cr
P/E (TTM): 28.7×Sector 43.8×
Promoter holding: 63.77%+0.00% QoQ
FII holding: 0.10%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Merger & Restructuring 2 Financial Results 2 Annual General Meeting 2 Management Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Oct 2026 15:15 IST BSE

Merger & Restructuring

Kilitch Drugs(I) Merger & Restructuring Worth ₹131.6 Cr

Kilitch Drugs will divest its entire Ethiopian subsidiary stake to HarmeeCare for US$14 million (~₹131.6 Crore). Proceeds will fund debt repayment and Pen plant expansion.

Value: ₹131.6 Cr

Open announcement → Read the filing ↗

22 Oct 2026 20:18 IST BSE

Merger & Restructuring

Kilitch Drugs(I) Merger & Restructuring Worth ₹120.8 Cr

Kilitch Drugs will divest its 100% stake in subsidiary Kilitch Estro Biotech PLC for USD 12.855 million (approx. ₹120.84 Crore).

Value: ₹120.8 Cr
From: HarmeeCare Pharmaceuticals

Open announcement → Read the filing ↗